C8 Health vs Implicity
openFDA lists three Implicity 510(k) clearances, including K230842 for the SignalHF heart failure risk score and K253463 for the ILR ECG Analyzer. openFDA lists no 510(k) under C8 Health, and the vendor makes no FDA claim.
An electrophysiology clinic running pacemaker and ICD follow-up buys Implicity. The vendor shows Abbott, Biotronik, Boston Scientific, Medtronic and MicroPort logos, calls the platform manufacturer-agnostic and claims 26% lower mortality than conventional remote monitoring. For C8 Health, the vendor describes helping hospitals reduce unwarranted clinical variation, and the customers it names include MetroHealth and UNC Anesthesiology. Its MetroHealth figures come from an internal 2024 study and show ERAS compliance rising from 65% to 88% in five months, reported by the vendor rather than a journal. Implicity's customers run device clinics for implanted heart devices, and C8's work centers on perioperative ERAS, glucose and infection protocols.
Decision support · Reviewed November 2, 2026

C8 Health
by C8 Health Inc. · founded 2019
Protocol knowledge platform for hospitals, with an AI assistant that answers only from the hospital's vetted content.
Implicity
by Implicity · founded 2016
Cloud platform for remote monitoring of pacemakers and ICDs, with AI alert filtering and heart failure risk scoring for device clinics.
When to pick each one
C8 Health
- Hospital protocols for surgical and anesthesia teams
- Vendor-reported ERAS compliance from 65% to 88%
Implicity
- Three FDA 510(k) clearances, latest in 2026
- Manufacturer-agnostic pacemaker and ICD remote monitoring
- AI heart failure risk alert, SignalHF
Score
Each row shows points earned of points available under the published rubric.
C8 Health
32of 100
Implicity
36of 100
| Dimension | C8 Health | Implicity | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 12 / 12 | -12 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 8.4 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 4.2 / 6 | 6 / 6 | -1.8 |
Scroll horizontally to see every column.
Pricing
C8 Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Implicity
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
C8 Health
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
1 PubMed record names C8 Health.
Implicity
FDA decisions
K253463 (opens in new tab)510(k)2026-07-02
ILR ECG Analyzer (IM007)
K230842 (opens in new tab)510(k)2023-10-25
SignalHF (IM008)
K210543 (opens in new tab)510(k)2021-11-03
IM007
Peer-reviewed
1 PubMed record names Implicity.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | C8 Health | Implicity |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2019 | 2016 |
| HQ | US | FR |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
